Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework

BACKGROUND: The rate of development of new orphan drugs continues to grow. As a result, reimbursing orphan drugs on an exceptional basis is increasingly difficult to sustain from a health system perspective. An understanding of the value that societies attach to providing orphan drugs at the expense...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulden, Mike, Stafinski, Tania, Menon, Devidas, McCabe, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342524/
https://www.ncbi.nlm.nih.gov/pubmed/25412735
http://dx.doi.org/10.1007/s40273-014-0235-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342524/
https://www.ncbi.nlm.nih.gov/pubmed/25412735
http://dx.doi.org/10.1007/s40273-014-0235-x

Ejemplares similares